Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 50,588.0 | 41,909.0 | 41,541.0 | 39,815.0 | 39,407.0 | 37,399.0 | 35,653.0 | 35,239.0 |
| Revenue growth | 20.7% | 0.9% | 4.3% | 1.0% | 5.4% | 4.9% | 1.2% | 2.1% |
| Cost of goods sold | 36,334.0 | 29,242.0 | 30,405.0 | 31,427.0 | 29,362.0 | 29,649.0 | 28,254.0 | 26,570.0 |
| Gross profit | 14,254.0 | 12,667.0 | 11,136.0 | 8,388.0 | 10,045.0 | 7,750.0 | 7,399.0 | 8,669.0 |
| Gross margin | 28.2% | 30.2% | 26.8% | 21.1% | 25.5% | 20.7% | 20.8% | 24.6% |
| Selling, general and administrative | 7,806.0 | 5,865.0 | 5,693.0 | 5,766.0 | 5,516.0 | 5,001.0 | 4,120.0 | 4,359.0 |
| EBITA | 7,359.0 | 7,448.0 | 5,980.0 | 3,196.0 | 5,224.0 | 3,121.0 | 3,635.0 | 4,492.0 |
| EBITA margin | 14.5% | 17.8% | 14.4% | 8.0% | 13.3% | 8.3% | 10.2% | 12.7% |
| Amortization of intangibles | 376.0 | 118.0 | 126.0 | 105.0 | 99.0 | 32.0 | | |
| EBIT | 6,983.0 | 7,330.0 | 5,854.0 | 3,091.0 | 5,125.0 | 3,089.0 | 3,635.0 | 4,492.0 |
| EBIT margin | 13.8% | 17.5% | 14.1% | 7.8% | 13.0% | 8.3% | 10.2% | 12.7% |
| Pre-tax income | 6,448.0 | 6,802.0 | 5,443.0 | 2,628.0 | 4,549.0 | 2,754.0 | 3,282.0 | 4,236.0 |
| Income taxes | 1,289.0 | 1,373.0 | 1,116.0 | 468.0 | 995.0 | 877.0 | 1,111.0 | 1,386.0 |
| Tax rate | 20.0% | 20.2% | 20.5% | 17.8% | 21.9% | 31.8% | 33.9% | 32.7% |
| Earnings from continuing ops | 5,078.0 | 5,314.0 | 4,158.0 | 2,012.0 | 3,438.0 | 1,761.0 | 2,055.0 | 2,746.0 |
| Earnings from discontinued ops | -3,593.0 | 147.0 | 520.0 | | | | | |
| Net income | 1,485.0 | 5,461.0 | 4,678.0 | 2,012.0 | 3,438.0 | 1,761.0 | 2,055.0 | 2,746.0 |
| Net margin | 2.9% | 13.0% | 11.3% | 5.1% | 8.7% | 4.7% | 5.8% | 7.8% |
| |
| Diluted EPS | $16.98 | $16.84 | $12.47 | $5.70 | $9.35 | $4.67 | $5.05 | $6.27 |
| Shares outstanding (diluted) | 299.1 | 315.5 | 333.5 | 353.2 | 367.8 | 377.3 | 406.8 | 438.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|